SCHEMBL29985302

SCHEMBL29985302

CC(C)(C)OC(=O)N1CC2(CNCO2)C1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NR1H2 P55055 2/20 0.36
RECQL P46063 1/20 0.35
HPGD P15428 1/20 0.34
EPHX2 P34913 1/20 0.34
SCD5 Q86SK9 1/20 0.33
DDB1 Q16531 2/20 0.33
CRBN Q96SW2 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
MAPK1 P28482 1/20 0.33
EPHX1 P07099 1/20 0.33
GPR183 P32249 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29984748 0.88 USP2 (0.42) USP2SMN1; SMN2NR1H2RECQLHPGD
SCHEMBL18418334 0.85 USP2 (0.47) USP2SMN1; SMN2RECQLHPGDEPHX2
SCHEMBL21193117 0.85 USP2 (0.44) USP2SMN1; SMN2NR1H2RECQLHPGD
SCHEMBL1489016 0.80 USP2 (0.50) USP2SMN1; SMN2NR1H2RECQLHPGD
SCHEMBL1247009 0.79 USP2 (0.51) USP2SMN1; SMN2NR1H2RECQLHPGD
SCHEMBL31401252 0.79 USP2 (0.41) USP2SMN1; SMN2NR1H2RECQLHPGD
Hydrochloric Acid SCHEMBL22776359 0.78 USP2 (0.50) USP2SMN1; SMN2NR1H2RECQLHPGD
SCHEMBL12654039 0.77 USP2 (0.51) USP2SMN1; SMN2NR1H2RECQLHPGD
SCHEMBL21886745 0.77 NR1H2 (0.39) USP2SMN1; SMN2NR1H2RECQLDDB1
SCHEMBL421751 0.75 USP2 (0.44) USP2SMN1; SMN2NR1H2RECQLHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118561952-A RAS inhibitors 锐新医药公司 2024-08-30 CN disclosed
EP-4346898-A1 METHODS FOR INHIBITING RAS Revolution Medicines, Inc. (US) 2024-04-10 EP disclosed
EP-4334321-A1 RAS INHIBITORS Revolution Medicines, Inc. (US) 2024-03-13 EP disclosed
WO-2022251292-A1 METHODS FOR INHIBITING RAS Revolution Medicines, Inc. (US) 2022-12-01 WO disclosed
WO-2022235864-A1 RAS INHIBITORS Revolution Medicines, Inc. (US) 2022-11-10 WO disclosed